KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Divestments (2020 - 2025)

Elanco Animal Health's Divestments history spans 4 years, with the latest figure at $9.0 million for Q1 2025.

  • On a quarterly basis, Divestments fell 86.36% to $9.0 million in Q1 2025 year-over-year; TTM through Dec 2025 was $9.0 million, a 99.34% decrease, with the full-year FY2025 number at $9.0 million, down 99.34% from a year prior.
  • Divestments hit $9.0 million in Q1 2025 for Elanco Animal Health, down from $1.3 billion in the prior quarter.
  • Over the last five years, Divestments for ELAN hit a ceiling of $1.3 billion in Q3 2024 and a floor of -$11.0 million in Q4 2022.
  • Historically, Divestments has averaged $273.8 million across 3 years, with a median of $11.0 million in 2022.
  • The widest YoY moves for Divestments: up 86.36% in 2025, down 86.36% in 2025.
  • Tracing ELAN's Divestments over 3 years: stood at -$11.0 million in 2022, then skyrocketed by 11863.64% to $1.3 billion in 2024, then tumbled by 99.3% to $9.0 million in 2025.
  • Business Quant data shows Divestments for ELAN at $9.0 million in Q1 2025, $1.3 billion in Q3 2024, and $66.0 million in Q1 2024.